Teniposide
SIGMA/SML0609 - ≥97% (HPLC)
Synonym: 4′-Dimethyl-9-(4,6-O-2-thenyid)-epipodophyllotoxin; Tenoposide; VM-26
CAS Number: 29767-20-2
Empirical Formula (Hill Notation): C32H32O13S
Molecular Weight: 656.65
EC Number: 249-831-2
Linear Formula: C32H32O13S
Product Type: Chemical
| assay | ≥97% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C32H32O13S/c1-37-19-6- |
| InChI key | NRUKOCRGYNPUPR-QBPJDGROSA |
| optical activity | [α]/D -100 to -115°, c = 1 in chloroform/methanol (9:1) |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | [s]1c(ccc1)[C@H]2O[C@@H]3 |
| solubility | DMSO: 10 mg/mL, clear |
| storage temp. | −20°C |
| Application: | Teniposide has been used as a topoisomerase II inhibitor to study its effects on the flagellum length in Trypanosoma brucei. It has also been used as a chemotherapeutic agent to study its interactions with piperazine(B87). |
| Biochem/physiol Actions: | Teniposide (VM-26) is a Topoisomerase II inhibitor with antitumor activity. Teniposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA, inducing breaks in double stranded DNA and preventing repair. |
| Biochem/physiol Actions: | Teniposide is a derivative of podophyllotoxin and has been studied to treat several cancers. It acts during the late S phase or the early G2 phase of the cell cycle. |
| Biochem/physiol Actions: | Teniposide is a Topoisomerase II inhibitor with antitumor activity. |
| Packaging: | 10, 50 mg in glass bottle |
| Symbol | GHS08 |
| Signal word | Danger |
| Hazard statements | H350 |
| Precautionary statements | P201 - P308 + P313 |
| Hazard Codes | T |
| Risk Statements | 45 |
| Safety Statements | 53-45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |


